Tingfei Hu
Overview
Explore the profile of Tingfei Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu T, Kalyanaraman H, Pilz R, Casteel D
J Biol Chem
. 2023 Mar;
299(4):104584.
PMID: 36889588
Cardiac contraction is modulated by the phosphorylation state of myosin regulatory light chain 2 (MLC-2v). The level of MLC-2v phosphorylation is dependent on the opposing activities of MLC kinases and...
2.
Aminzai S, Hu T, Pilz R, Casteel D
J Biol Chem
. 2022 Jun;
298(8):102175.
PMID: 35752367
Type I cGMP-dependent protein kinases (PKGIs) are important components of various signaling pathways and are canonically activated by nitric oxide- and natriuretic peptide-induced cGMP generation. However, some reports have shown...
3.
Chan M, Aminzai S, Hu T, Taran A, Li S, Kim C, et al.
J Biol Chem
. 2020 Jun;
295(30):10394-10405.
PMID: 32506052
Type 1 cGMP-dependent protein kinases (PKGs) play important roles in human cardiovascular physiology, regulating vascular tone and smooth-muscle cell phenotype. A mutation in the human PRKG1 gene encoding cGMP-dependent protein...
4.
Cantillon D, Tarakji K, Hu T, Hsu A, Smedira N, Starling R, et al.
Heart Rhythm
. 2010 Jul;
7(11):1567-71.
PMID: 20601151
Background: Pacemaker-requiring bradyarrhythmias after cardiac transplantation are common, and rarely can lead to sudden cardiac death. Prior outcomes studies have been limited to single-center data. Objective: This study sought to...
5.
Bayturan O, Tuzcu E, Uno K, Lavoie A, Hu T, Shreevatsa A, et al.
Am J Cardiol
. 2010 Jun;
105(12):1735-9.
PMID: 20538123
Diabetes mellitus (DM) and metabolic syndrome (MS) are associated with adverse cardiovascular outcomes. However, the extent and progression of coronary atherosclerosis for these conditions have not been directly compared. Three...
6.
Tarakji K, Chan E, Cantillon D, Doonan A, Hu T, Schmitt S, et al.
Heart Rhythm
. 2010 May;
7(8):1043-7.
PMID: 20470904
Background: Indications for cardiac implantable electronic devices (CIEDs) are increasing. Although CIED infections occur infrequently, the impact of this outcome is expected to be substantial. Objective: The purpose of this...
7.
Bayturan O, Tuzcu E, Lavoie A, Hu T, Wolski K, Schoenhagen P, et al.
Arch Intern Med
. 2010 Mar;
170(5):478-84.
PMID: 20212186
Background: The mechanism that confers adverse cardiovascular prognosis in patients with the metabolic syndrome (MetS) remains unclear. We sought to investigate the association of MetS and its component risk factors...
8.
Eikelboom J, Hankey G, Thom J, Bhatt D, Steg P, Montalescot G, et al.
Circulation
. 2008 Oct;
118(17):1705-12.
PMID: 18838564
Background: Incomplete inhibition of platelet thromboxane generation, as measured by elevated urinary 11-dehydro thromboxane B(2) concentrations, has been associated with an increased risk of cardiovascular events. We aimed to determine...
9.
Brener S, Ivanc T, Hu T
J Invasive Cardiol
. 2008 Jun;
20(6):261-5.
PMID: 18523316
Background: While favorable changes in atherogenic lipids are indisputably associated with improved clinical outcomes, a similar correlation with quantitative coronary angiography (QCA) parameters is more difficult to document. Objective: To...
10.
Hart R, Bhatt D, Hacke W, Fox K, Hankey G, Berger P, et al.
Cerebrovasc Dis
. 2008 Feb;
25(4):344-7.
PMID: 18303254
Background: Aspirin offers modest reduction in stroke in patients with atrial fibrillation. Whether combination of aspirin with clopidogrel offers additional protection is unclear. Methods: Post-hoc subgroup analysis of 593 participants...